Metformin Sandoz (Metformin Hydrochloride)

Metformin Sandoz, a biguanide antidiabetic, is used to manage hyperglycemia in type 2 diabetes and related conditions.

• Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial glucose levels.
• Impaired glucose tolerance: helps delay progression to overt diabetes when combined with lifestyle measures.
• Polycystic ovary syndrome: may improve insulin resistance and menstrual regularity in affected women.

• Metformin Hydrochloride acts primarily by inhibiting hepatic gluconeogenesis and decreasing intestinal glucose absorption. It activates AMP‑activated protein kinase (AMPK), which enhances insulin‑mediated glucose uptake in peripheral tissues and reduces lipogenesis, thereby improving overall insulin sensitivity without directly stimulating insulin secretion.

Metformin Sandoz may cause a range of adverse reactions, most of which are related to the gastrointestinal system.

Common Side Effects

• Nausea: mild to moderate feeling of sickness.
• Diarrhea: loose stools, often transient.
• Abdominal discomfort: cramping or pain in the stomach area.
• Metallic taste: persistent metallic sensation in the mouth.
• Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects

• Lactic acidosis: buildup of lactic acid, a medical emergency.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Hypoglycemia: low blood sugar, usually when combined with other antidiabetic agents.
• Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

When prescribing Metformin Sandoz, several safety considerations should be observed.

• Renal function assessment: evaluate eGFR before initiating and periodically thereafter.
• Lactic acidosis risk: avoid in patients with severe renal impairment, hepatic disease, or excessive alcohol intake.
• Alcohol consumption: limit intake to reduce risk of metabolic acidosis.
• Surgery or radiographic contrast: temporarily discontinue metformin before and after the procedure.
• Pregnancy and lactation: use only if potential benefits justify potential risks to the fetus or infant.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and heat.

Metformin Sandoz can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate renal failure; hold metformin before and after imaging.
• Cimetidine: increases metformin plasma concentrations, raising risk of toxicity.
• Alcohol: synergistic effect increasing risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask symptoms of hypoglycemia.
• Diuretics: can affect renal clearance of metformin.
• ACE inhibitors or ARBs: require monitoring of renal function and electrolytes.
• Thyroid hormones: may influence glucose metabolism, necessitating glucose monitoring.